FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/VTRS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $19.22, up 2.95% today, with a bullish technical signal from moving averages and a consensus analyst price target of $21.00. The company reported Q2 2026 EPS of $0.69, beating expectations, and maintains strong operating cash flow of $2.32 billion in 2025. Recent news highlights include FDA approval for WAKIX in Japan and recognition as a top employer by Forbes.
The outlook is cautiously optimistic, supported by earnings beats and deleveraging progress, but risks include negative net income margins and high debt levels. Upside potential exists if operational improvements continue, though investors should monitor profitability trends and competitive pressures in the healthcare sector.
Read full analysis

Key Stats

  • Market Cap
    $21.73B
  • Volume
    7,549,918
  • Sector
    Health
  • 52W High
    $19.20
  • 52W Low
    $10.11
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $33.85B
  • Div Yield
    2.54%
  • Trading Activity
    -
$19.4
52W Low: $10.11
06 Nov 2025
52W High: $19.4
04 Nov 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $10.11 and a high of $19.4, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

Chery unveils automotive-grade AI for robots and eVTOLs, advancing safe physical AI beyond vehicles.

At the 2026 Chery International User Summit, Chery Auto showcased its new physical AI technology built on decades of automotive safety data and engineering. Their CheryMind AI model and CHERY All-World Engine support autonomous robots, robotaxis, and...

Market News
1 hour ago
Na
Bullish
news icon
Chery unveils automotive-grade AI for robots and eVTOLs, advancing safe physical AI beyond vehicles.

3M agrees to $7.35B settlement for PFAS exposure claims affecting up to 120,000 people.

3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...

Market News
4 hours ago
Rafferty Domnick Cunningham & Yaffa
Bearish
news icon
3M agrees to $7.35B settlement for PFAS exposure claims affecting up to 120,000 people.

Global e-learning market to reach $506.6B by 2032, growing 10.62% annually driven by corporate upskilling and digital access.

The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...

Market News
4 hours ago
Mordor Intelligence
Bullish
news icon
Global e-learning market to reach $506.6B by 2032, growing 10.62% annually driven by corporate upskilling and digital access.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $21.73B
  • Volume
    7,549,918
  • Sector
    Health
  • 52W High
    $19.20
  • 52W Low
    $10.11
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $33.85B
  • Div Yield
    2.54%
  • Trading Activity
    -
$19.4
52W Low: $10.11
06 Nov 2025
52W High: $19.4
04 Nov 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $10.11 and a high of $19.4, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!